-
Mashup Score: 1GN’s Jabra sends self-fitting hearing aids to market for $799 ahead of FDA over-the-counter ruling - 4 year(s) ago
The Enhance Plus earbuds have been cleared by the FDA as self-fitting hearing aids.
Source: FierceBiotechCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Tasso, Vault Health team up to provide at-home blood testing for siteless clinical trials - 4 year(s) ago
Tasso’s push-button blood collection device attaches to the upper arm and draws a sample from the skin’s capillaries.
Source: FierceBiotechCategories: Future of Medicine, Latest HeadlinesTweet-
.@TassoInc @vaulthealth team up to provide at-home #bloodtesting for siteless #clinicaltrials | #decentralized #wearables https://t.co/nBKzplAfuw https://t.co/L9JhiTDhyT
-
-
Mashup Score: 2Remote possibilities: United BioSource teams with Seqster to boost decentralized study offering - 4 year(s) ago
Decentralized trials are here to stay, says United BioSource, which has partnered with “patient centric” healthcare tech firm Seqster PDM to bolster its remote study business.
Source: FierceBiotechCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @cafepharma: Remote possibilities: United BioSource teams with Seqster to boost decentralized study offering https://t.co/V0vooWYdoB
-
-
Mashup Score: 2Tasso, Vault Health team up to provide at-home blood testing for siteless clinical trials - 4 year(s) ago
Tasso’s push-button blood collection device attaches to the upper arm and draws a sample from the skin’s capillaries.
Source: FierceBiotechCategories: Healthcare Professionals, Latest HeadlinesTweet-
This announcement doesn't just fit into my "at-home lab testing is skyrocketing" theme, but through that I also learnt that there is a company working on a wearable blood collection device. They are now pairing up with telehealth provider Vault Health. https://t.co/icTAT0DolL
-
-
Mashup Score: 342Pfizer's $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies - 4 year(s) ago
Pfizer is taking its Valneva-partnered Lyme disease vaccine into phase 3. With midphase data supporting a three-dose series, the allies plan to kick off a phase 3 clinical trial of the regimen in the third quarter.
Source: FierceBiotechCategories: Infectious Disease, Latest HeadlinesTweet-
Progress on the Lyme disease vaccine front: Press release data suggests that vaccine candidate VLA15 was safe and immunogenic in a Phase 2 study & there are plans to move ahead with a Phase 3 clinical trial. Fingers tightly crossed. https://t.co/DHPwpJoUnA https://t.co/nj3Kc3fUb7
-
-
Mashup Score: 2
Provention Bio has won the go-ahead from the FDA to resubmit its application for a therapy to delay diabetes, which has been on hold since the agency questioned whether the planned commercial product was comparable to the drug used in historical trials.
Source: FierceBiotechCategories: Endocrinology, Latest HeadlinesTweet-
RT @DrBobGabbay: Hopeful news on the possibility of the first treatment to prevent #diabetes #T1D https://t.co/G4rFI4CB0N
-
-
Mashup Score: 0Does the world need more COVID-19 vaccines? These companies think there's still room for improvement - 4 year(s) ago
The ultimate COVID-19 vaccine will be able to tackle all emerging coronavirus strains, easy to store and quick to manufacture. And yes, there’s still time for the stragglers who were beaten to the punch by Pfizer, BioNTech and Moderna—at least according to the companies still trying to get in line.
Source: FierceBiotechCategories: Hem/Oncs, Latest HeadlinesTweet-
Does the world need more COVID-19 vaccines? https://t.co/tjxmIy5hsD via @AGKootenay & @ky_lahucik
-
-
Mashup Score: 0Doctor groups urge Biden administration to disclose costs of federally funded clinical trials - 4 year(s) ago
International nonprofits and doctor groups are calling for the U.S. government to disclose the cost of federally funded clinical trials and are urging President Joe Biden to nominate a National Institutes of Health director who will ensure biopharmas reveal that R&D figure to the public.
Source: FierceBiotechCategories: Hem/Oncs, Latest HeadlinesTweet-
Doctor groups @MSF_USA , @drsforamerica , @DNDi urge Biden administration to disclose costs of @NIH funded clinical trials https://t.co/ozLCiboicI via @ky_lahucik
-
-
Mashup Score: 1
Sensor maker Rockley Photonics reported that a pilot study of its wrist-worn device was able to measure a person’s blood pressure without the squeeze of a cuff.
Source: FierceBiotechCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @JonKlett: Apple partner Rockley Photonics’ wearable blood pressure sensors clear pilot study https://t.co/M40pumLOyO
-
-
Mashup Score: 0
The algorithm looks for changes in the tiny blood vessels feeding the back of the eye and the complex patterns linked to broader cardiovascular disease.
Source: FierceBiotechCategories: Future of Medicine, Latest HeadlinesTweet-
Could the information you need to gauge your risk of a #heartattack within the next year be found in your eyes? Researchers from @UniversityLeeds have trained an #AI algorithm to spot the warning signs. https://t.co/FFqLKuok0y
-
GN’s @Jabra_US sends self-fitting #hearingaids to market for $799 ahead of #FDA over-the-counter #OTC ruling https://t.co/1wwPCjkM7C